|Bid||93.28 x 800|
|Ask||93.49 x 800|
|Day's Range||92.01 - 93.92|
|52 Week Range||81.66 - 100.15|
|Beta (3Y Monthly)||0.66|
|PE Ratio (TTM)||26.27|
|Earnings Date||Aug 20, 2019|
|Forward Dividend & Yield||2.00 (2.25%)|
|1y Target Est||103.28|
May 24, 2019 - Medtronic plc (MDT), the global leader in medical technology, today announced that it will participate in the Bernstein 35th Annual Strategic Decisions Conference on Wednesday, May 29, 2019, in New York City. Omar Ishrak, chairman and chief executive officer of Medtronic, will make a presentation and will answer questions about the company beginning at 10:00 a.m. EDT (9:00 a.m. CDT). Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world`s largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world.
Investing to "buy and hold" is trickier than it looks. The increasing pace of technological change means even the most successful, dominant companies have to continually adapt to keep up. Industries like energy, real estate and even consumer products are facing potentially significant long-term changes going forward. In any era, amassing a collection of retirement stocks simply by buying the best companies and holding them for years can be a risky endeavor.General Motors (GM) was a classic "widows and orphans" stock until last decade, when GM wound up going bankrupt. United States Steel (X) once was a pillar of corporate America and a buy-and-hold stock. GM shares basically haven't moved in a quarter of a century. Polaroid and Eastman Kodak were once blue-chip stocks. Both went bankrupt as cameras changed from film to digital.But there still are stocks to buy and hold out there that can last forever, while offering dividend income along the way.Here are ten such retirement stocks to hold forever. SEE ALSO FROM KIPLINGER: 19 Best Retirement Stocks to Buy
Medtronic posted a "solid quarter" on Thursday, one analyst said, though she noted diabetes device revenue only met expectations and cardiac sales lagged estimates from Wall Street analysts.
Check out the companies making headlines midday Thursday:L Brands LB — L Brands surged 12.8% after the parent company of Victoria's Secret and Bath & Body Works reported first-quarter earnings that surpassed expectations .
Medtronic Plc reported quarterly profit ahead of estimates on strong demand for its surgical instruments and forecast better-than-expected 2020 earnings on Thursday, sending shares of the medical device maker up nearly 3%. The company has been building its minimally invasive and robotic surgery device businesses through new launches and acquisitions to ease the impact of rising competition it faces at its top-earning cardiac and vascular unit. There had been growing concerns among investors after the U.S. regulators raised safety concerns about Medtronic's drug-coated balloons, which is part of the company's biggest selling unit, as well as a recent closure of a plant that Medtronic uses to sterilize its surgical instruments.
While pre-market futures are down on a continued souring in trade between the U.S. and China, Jobless Claims, Best Buy and Medtronic brought some good news.
gained on Thursday after the company reported fiscal fourth-quarter earnings that beat analysts' forecasts and offered an upbeat assessment of its prospects for fiscal 2020. Shares of Medtronic gained 2.25% to $90.76 in trading on the New York Stock Exchange after the company reported adjusted net income of $1.94 billion, or $1.42 a share, vs. $1.47 billion, or $1.07 a share, in the comparable year-earlier period. For the full year Medtronic said it earned an adjusted $5.22 a share, above FactSet consensus estimates of $5.15.
Excluding the Diabetes group, Medtronic (MDT) displays better performances at CER on the back of growth in rest of the business segments and across all geographies.
Medtronic on Thursday reported a 20 percent slide in fourth-quarter earnings, but the medical-technology giant still beat Wall Street estimates, bolstered by growth in its minimally invasive and robot-assisted surgery systems.
Medtronic (MDT) delivered earnings and revenue surprises of 5.48% and 0.46%, respectively, for the quarter ended April 2019. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Dublin-based company said it had profit of 87 cents. Earnings, adjusted for one-time gains and costs, were $1.54 per share. The results beat Wall Street expectations. The average ...
Medtronic Plc. said Thursday it had net income of $1.172 billion, or 87 cents a share, in its fiscal fourth quarter to April 26, down from $1.460 billion, or $1.07 a share, in the year-earlier period. Adjusted per-share earnings came to $1.54, ahead of the $1.46 FactSet consensus. Sales were little changed at $8.146 billion compared with $8.144 billion a year ago, also ahead of the $8.108 billion FactSet consensus. U.S. revenue of $4.284 billion accounted for 52% of overall revenue and was up 2.3%. The company said it now expects fiscal 2020 adjusted EPS of $5.44 to $5.50, which compares with a current FactSet consensus of $5.44. "We expect our revenue growth to accelerate over the course of fiscal year 2020 and into fiscal year 2021, driven by the anniversary of recent headwinds, combined with a series of major product launches over the next 12 months," Chief Executive Omar Ishrak said in a statement. Shares rose 1.4% premarket, and are up 4.1% in the last 12 months, while the S&P 500 has gained 4.5%.
Medtronic Plc reported a nearly 20% drop in quarterly profit on Thursday, hurt by lower sales in its cardiac and vascular business that makes heart valves and stents. Net income attributable to the company ...
Q4 Revenue of $8.1 Billion, Flat as Reported and Grew 3.6% Organic Q4 GAAP Diluted EPS of $0.87; Q4 Non-GAAP Diluted EPS of $1.54 FY19 Revenue of $30.6 Billion Grew 2.0% Reported and 5.5% Organic FY19 ...
Investing.com - Medtronic (NYSE:MDT) reported fourth quarter earnings that beat analysts' expectations on Thursday and revenue that topped forecasts.